Does insulin resistance predict complete response in breast cancer patients who underwent neoadjuvant treatment?

Basit Öğe Kaydı
dc.authorid0000-0001-6535-6030
dc.contributor.authorAlan, Ozkan
dc.contributor.authorTelli, Tugba Akin
dc.contributor.authorAktas, Bilge
dc.contributor.authorKoca, Sinan
dc.contributor.authorOkten, Ilker N.
dc.contributor.authorTuylu, Tugba Basoglu
dc.contributor.authorDemircan, Nazim C.
dc.date.accessioned2025-05-10T19:41:05Z
dc.date.issued2020
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description42nd Annual San Antonio Breast Cancer Symposium -- DEC 09-14, 2019 -- San Antonio, TX
dc.description.abstract[No abstract available]
dc.identifier.doi10.1158/1538-7445.SABCS19-P2-16-18
dc.identifier.issn0008-5472
dc.identifier.issn1538-7445
dc.identifier.issue4
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1158/1538-7445.SABCS19-P2-16-18
dc.identifier.urihttps://hdl.handle.net/20.500.14730/10187
dc.identifier.volume80
dc.identifier.wosWOS:000527012501191
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherAmer Assoc Cancer Research
dc.relation.ispartofCancer Research
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleDoes insulin resistance predict complete response in breast cancer patients who underwent neoadjuvant treatment?
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu